缓释性辅料市场规模、份额及成长分析（按类型、技术、给药途径及地区）- 产业预测 2025-2032

缓释缓释性市场规模预计在 2023 年达到 16 亿美元，并从 2024 年的 17.3 亿美元成长到 2032 年的 32.3 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.1%。

受慢性病发病率上升和对创新药物输送系统的需求增加的推动，全球缓释性辅料市场正在经历强劲增长。缓释性製剂能逐渐释放药物，提高病患的遵从性和治疗效果，辅料已成为各种剂型中不可或缺的。赋形剂技术的最新进展，包括新型聚合物和涂层，正在扩大可用的配方选择。从跨国公司到专业公司，主要企业都在积极投资研究并建立伙伴关係来生产定製配方。虽然北美和欧洲引领市场，但亚太和拉丁美洲等新兴地区也正在迅速扩张。随着对精准医疗和个人化治疗的关注，以及对复杂辅料解决方案的需求增加，未来前景光明。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究

缓释性辅料市场规模（按类型和复合年增长率） （2025-2032）

• 市场概况
• 明胶
• 聚合物
• 矿物
• 糖
• 其他的

缓释性辅料市场规模（依技术及复合年增长率） (2025-2032)

• 市场概况
• 定向投放
• 微囊化
• 沃斯特技术
• 其他的

缓释性辅料市场规模（依给药途径及复合年增长率） (2025-2032)

• 市场概况
• 口服
• 肌肉注射
• 皮下
• 经皮
• 静脉
• 其他的

缓释性辅料市场规模（依地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• International Flavors & Fragrances Inc.（United States）
• Evonik Industries AG（Germany）
• BASF SE（Germany）
• Kerry Group Plc（Ireland）
• Roquette Freres（France）
• Merck KGaA（Germany）
• Associated British Foods Plc（United Kingdom）
• ADM（United States）
• Wacker Chemie AG（Germany）
• Croda International Plc（United Kingdom）
• Gattefosse（France）
• Colorcon Inc.（United States）
• AstraZeneca PLC（United Kingdom）
• GlaxoSmithKline PLC（United Kingdom）
• Mayne Pharma Group Limited（Australia）
• Sun Pharmaceutical Industries Ltd.（India）
• Pfizer Inc.（United States）
• Novartis AG（Switzerland）

结论和建议

Sustained Release Excipients Market size was valued at USD 1.6 billion in 2023 and is poised to grow from USD 1.73 billion in 2024 to USD 3.23 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The global sustained release excipients market is experiencing robust growth, fueled by a rising prevalence of chronic diseases and an increased demand for innovative drug delivery systems. As sustained release formulations facilitate gradual drug release, they enhance patient compliance and therapeutic effectiveness, making their excipients vital in various dosage forms. Recent advancements in excipient technologies, including novel polymers and coatings, broaden the formulation options available. Key players, ranging from multinational firms to specialized companies, are actively investing in research and forging partnerships to create customized formulations. While North America and Europe lead the market, emerging regions like Asia-Pacific and Latin America are also expanding rapidly. The future looks bright, with a focus on precision medicine and personalized therapies driving demand for sophisticated excipient solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Sustained Release Excipients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Sustained Release Excipients Market Segments Analysis

Global Sustained Release Excipients Market is segmented by Type, Technology, Route of Administration and region. Based on Type, the market is segmented into Gelatin, Polymers, Minerals, Sugars and Others. Based on Technology, the market is segmented into Targeted Delivery, Microencapsulation, Wurster Technique and Others. Based on Route of Administration, the market is segmented into Oral, Intramuscular, Subcutaneous, Transdermal, Intravenous and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Sustained Release Excipients Market

The Sustained Release Excipients market is significantly influenced by the aging global population, which is reshaping demographic trends and leading to increased demand for healthcare products and pharmaceuticals. These excipients offer notable advantages, including prolonged drug release, which enhances patient compliance and is particularly beneficial for managing chronic conditions prevalent among elderly individuals. As healthcare providers seek to address the unique challenges posed by this demographic shift, the necessity for medications tailored to the needs of older patients becomes increasingly apparent. Consequently, this trend is expected to sustain a consistent demand for sustained release excipients within the pharmaceutical industry.

Restraints in the Sustained Release Excipients Market

The Sustained Release Excipients market faces significant constraints due to stringent regulations that govern drug approval and release within the pharmaceutical industry. This complex regulatory framework presents substantial challenges, as companies must navigate lengthy approval processes while ensuring compliance, resulting in high costs and time commitments. Additionally, frequent updates to regulatory standards and guidelines can lead to unforeseen delays in product development and market launch. Such obstacles not only impede the timely introduction of new products but also hinder overall market growth, making it crucial for companies to carefully manage their approaches to meet these requirements effectively.

Market Trends of the Sustained Release Excipients Market

The Sustained Release Excipients market is witnessing a significant trend towards increased focus on personalized medicine, propelled by advancements in biomarker identification and genomics. As the pharmaceutical industry pivots towards tailored therapeutics that cater to individual patient profiles, the demand for sustained release excipients is escalating. These excipients facilitate precise dosing and optimized timing of drug release, enhancing therapeutic outcomes while reducing side effects. This trend aligns with the broader shift towards patient-centric healthcare and is fostering innovation in excipient formulations and technologies, ultimately supporting the development of more effective and personalized drug delivery systems.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Sustained Release Excipients Market Size by Type & CAGR (2025-2032)

• Market Overview
• Gelatin
• Polymers
• Minerals
• Sugars
• Others

Global Sustained Release Excipients Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Targeted Delivery
• Microencapsulation
• Wurster Technique
• Others

Global Sustained Release Excipients Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Oral
• Intramuscular
• Subcutaneous
• Transdermal
• Intravenous
• Others

Global Sustained Release Excipients Market Size & CAGR (2025-2032)

• North America (Type, Technology, Route of Administration)
  • US
  • Canada
• Europe (Type, Technology, Route of Administration)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Technology, Route of Administration)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Technology, Route of Administration)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Technology, Route of Administration)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• International Flavors & Fragrances Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roquette Freres (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Associated British Foods Plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ADM (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wacker Chemie AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Croda International Plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gattefosse (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayne Pharma Group Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations